Advanced Prostate Cancer VL

ADT and the Mechanisms of Cardiovascular Disease- E. David Crawford

Details
The following presentation was made at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6) E. David Crawford presents the potential mechanisms for differences in cardiovascular risk with different forms of ADT including; metabolic status, exacerbation of underlying cardiovascular disease (CVD) and preclinical data. In addition, a discussion on the need for the risk of CVD to be assessed...

Mack Roach and Martin Spahn on 'Oligometastases: RP is experimental and should only be done in the context of a prospective clinical trial’ versus 'RP and SBRT to bone disease is a reasonable manageme...

Details
Dr. Mack Roach and Dr. Martin Spahn presented a debate on “Oligometastases: RP Is Experimental and Should Only Be Done in the Context of a Prospective Clinical Trial” versus “RP and SBRT to Bone Disease Is a Reasonable Management Strategy for Men with Oligomets” at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6) Biographies: Mack Roach III, MD Martin Spahn, MD , currently Senior Con...

Thomas Keane on Vitamin D and Prostate Cancer - STOP 6

Details
Prostate Cancer and Vitamin D (STOP 6) Biography: Thomas E. Keane, MBBCh, FRCSI, FACS

Piet Ost on The impact of local treatment of the prostate in patients with newly diagnosed metastatic prostate cancer - STOP 6

Details
The impact of local treatment of the prostate in patients with newly diagnosed metastatic prostate cancer (STOP 6) Biography: Piet Ost, MD, PhD is the adjunct head of the Radiation oncology clinic, part of the Ghent University Hospital. He is an assistant professor and part of the faculty of Medicie and Health Sciences at the University of Ghent. Dr. Ost is a member of the Steering Committee of IO...

Bone Targeted Agents in Metastatic Prostate Cancer: Denosumab, Bisphosphonates and Radium-223 - Noel Clarke

Details
This video lecture presentations took place at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), in Lisbon, Portugal between in October 2016. The meeting was organised by Bioscript and the Scientific Committee, composed of Professors Laurence Klotz (Chair), Noel Clarke, Karim Fizazi and Bertrand Tombal. Noel Clarke, MD, discusses the biology of different bone targeted agents in metas...

Noel Clarke on Combination Treatment in Hormone-sensitive Prostate Cancer - STOP 6

Details
Combination Treatment in Hormone-sensitive Prostate Cancer (STOP 6) Biography: Noel Clarke, MD

Noel Clarke on Clinical applications of molecular genetics in prostate cancer - STOP 6

Details
Clinical applications of molecular genetics in prostate cancer (STOP 6) Biography: Noel Clarke, MD

Nicolas Mottet on EAU Guidelines for patients monitoring under treatment - STOP 6

Details
This video lecture presentations took place at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), in Lisbon, Portugal between in October 2016. The meeting was organised by Bioscript and the Scientific Committee, composed of Professors Laurence Klotz (Chair), Noel Clarke, Karim Fizazi and Bertrand Tombal. Nicolas Mottet presents a summary of the 2016 version of the European Association...

Nicolas Mottet on Managing the primary in elderly/unfit patients - STOP 6

Details
Managing the primary in elderly or unfit patients (STOP 6) Biography: Nicolas Mottet, MD, PhD

New Concepts in Androgen Deprivation Therapy (ADT) Agonists vs. Antagonists and All the Rest- Tom Keane

Details
Thomas Keane's video lecture is a state of the art review of personalized androgen deprivation therapy (ADT) for men being treated for advanced prostate cancer. This discussion includes the most recent data and considerations relative to identifying patients with cardiovascular disease, obesity and testosterone, fatty acid synthase (FSH) and adipogenous, high volume metastatic disease, use of doce...
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe